Ayala Pharmaceuticals (STU:FAD) Change In Prepaid Assets : €0.13 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Ayala Pharmaceuticals Change In Prepaid Assets?

Ayala Pharmaceuticals's Change In Prepaid Assets for the quarter that ended in Dec. 2023 was €0.09 Mil. It means Ayala Pharmaceuticals's Prepaid Assets increased by €0.09 Mil from Sep. 2023 to Dec. 2023 .

Ayala Pharmaceuticals's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was €-1.37 Mil. It means Ayala Pharmaceuticals's Prepaid Assets declined by €1.37 Mil from Dec. 2022 to Dec. 2023 .

Ayala Pharmaceuticals Change In Prepaid Assets Historical Data

The historical data trend for Ayala Pharmaceuticals's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ayala Pharmaceuticals Change In Prepaid Assets Chart

Ayala Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Prepaid Assets

Get a 7-Day Free Trial

0.15

-0.85

-1.04

2.11

-1.37

Ayala Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Change In Prepaid Assets	Get a 7-Day Free Trial															0.79	1.06	-	0.04	0.09

Ayala Pharmaceuticals Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.13 Mil.

Ayala Pharmaceuticals Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Ayala Pharmaceuticals's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Ayala Pharmaceuticals (STU:FAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ayala Pharmaceuticals Inc (STU:FAD) » Definitions » Change In Prepaid Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Oppenheimer 4, Rehovot, ISR, 7670104

Website

https://www.ayalapharma.com

Ayala Pharmaceuticals Inc clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. The company's current portfolio of product candidates, AL101 and AL102, targets the aberrant activation of the Notch pathway with gamma-secretase inhibitors. Its product candidate, AL101, is being developed as a potent, selective, injectable small molecule gamma-secretase inhibitor, or GSI. It is also developing AL101 for the treatment of T-ALL, an aggressive, rare form of T-cell-specific leukemia.